View:
Download DOC
Download PDF
SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940 		 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Snell Kristi
(Last) (First) (Middle)
C/O METABOLIX, INC.
19 PRESIDENTIAL WAY
(Street)
WOBURN MA 01801
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
10/17/2016 		3. Issuer Name and Ticker or Trading Symbol
METABOLIX, INC. [ MBLX ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
VP Research & CSO
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 18,208 D
Common Stock 23,700 I By 401(k) Plan(1)
Common Stock 43,749(6) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) (2) 03/05/2018 Common Stock 417 90 D
Stock Option (right to buy) (2) 05/30/2018 Common Stock 2,500 67.32 D
Stock Option (right to buy) (2) 10/21/2018 Common Stock 1,400 54.72 D
Stock Option (right to buy) (2) 08/21/2019 Common Stock 1,333 63.24 D
Stock Option (right to buy) (2) 02/12/2020 Common Stock 1,667 58.62 D
Stock Option (right to buy) (2) 02/11/2021 Common Stock 1,667 54.72 D
Stock Option (right to buy) (2) 02/01/2022 Common Stock 3,334 15.96 D
Stock Option (right to buy) (2) 05/31/2022 Common Stock 3,334 12 D
Stock Option (right to buy) (2) 09/18/2022 Common Stock 10,000 9.3 D
Stock Option (right to buy) (3) 02/13/2023 Common Stock 1,667 10.08 D
Stock Option (right to buy) (4) 07/22/2023 Common Stock 4,167 8.88 D
Stock Option (right to buy) (5) 02/24/2024 Common Stock 5,001 7.74 D
Explanation of Responses:
1. Shares acquired as Company matching contributions under the Metabolix, Inc. 401(k) Plan.
2. This option is fully vested and exercisable.
3. This option vests and becomes exercisable in 16 equal quarterly installments over a period of 4 years from 2/13/13.
4. This option vests and becomes exercisable in 16 equal quarterly installments over a period of 4 years from 7/22/13.
5. This option vests and becomes exercisable in 16 equal quarterly installments over a period of 4 years from 2/24/14.
6. These securities are in the form of restricted stock units ("RSUs") issued under the Issuer's 2014 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in three equal annual installments on 4/1/17, 4/1/18 and 4/1/19. All RSUs that have not vested will terminate upon the reporting person's termination of employment with the Issuer and its subsidiaries.
/s/ Sarah P. Cecil, attorney-in-fact 10/26/2016
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Exhibit 24

POWER OF ATTORNEY

KNOW ALL MEN BY THESE PRESENTS, that the undersigned
hereby constitutes and appoints Sarah P. Cecil,
Charles B. Haaser, John M. Mutkoski, and any one of
them acting singly, the true and lawful attorneys-in-
fact and agents, with full power of substitution and
resubstitution, for the undersigned and in the
undersigned's name, place and stead, in any and all
capacities (until revoked in writing) to execute for
and on behalf of the undersigned, in any and all of
the undersigned's capacities, any and all statements
on Forms 3, 4 and 5 with respect to the undersigned's
holdings of and transactions in securities issued by
Metabolix, Inc. (the "Company") in accordance with
Sections 16(a) of the Securities Exchange Act of 1934,
as amended (the "Exchange Act"), and any and all
regulations promulgated thereunder, and to file the
same, with all exhibits thereto, and any other
documents in connection therewith, with the Securities
and Exchange Commission, and with any other entity
when and if such is mandated by the Exchange Act or by
the By-laws of the National Association of Securities
Dealers, granting unto said attorneys-in-fact and
agents full power and authority to do and perform each
and every act and thing requisite and necessary fully
to all intents and purposes as the undersigned might
or could do in person thereby ratifying and confirming
all that said attorneys-in-fact and agents, or their
substitute or substitutes, may lawfully do or cause to
be done by virtue hereof.

This Power of Attorney shall remain in full force and
effect until the undersigned is no longer required to
file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in
securities issued by the Company, unless earlier
revoked by the undersigned in a signed writing
delivered to the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, this Power of Attorney has been
signed as of October 24, 2017.

Signature:	/s/ Kristi Snell
Name:  Kristi Snell